Alpha Teknova, Inc. Common Stock TKNO
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-04T00:55:30.335Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:00:01.110643416Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-04T00:55:29.951414+00:00
Alpha Teknova, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 5.78 | 147.4% | 26.6% | |||
| 25Δ | 6.11 | 147.8% | 23.7% | |||
| 30Δ | 6.44 | 148.2% | 20.9% | |||
| 35Δ | 10.48 | 247.0% | 52.3% | 6.77 | 148.6% | 18.1% |
| 40Δ | 9.44 | 214.9% | 38.6% | 7.10 | 149.0% | 15.2% |
| 45Δ | 8.74 | 191.5% | 29.9% | 7.43 | 149.4% | 12.4% |
| 50Δ | 8.05 | 168.1% | 21.1% | 7.86 | 152.8% | 10.8% |
| 55Δ | 7.43 | 149.7% | 13.8% | 8.31 | 157.1% | 9.5% |
| 60Δ | 7.09 | 150.6% | 12.1% | 8.75 | 161.3% | 8.2% |
| 65Δ | 6.75 | 151.5% | 10.4% | 9.20 | 165.5% | 6.9% |
| 70Δ | 6.41 | 152.4% | 8.7% | 9.65 | 169.7% | 5.6% |
| 75Δ | 6.07 | 153.3% | 7.1% | 10.59 | 188.0% | 4.6% |
| 80Δ | 5.73 | 154.2% | 5.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.78
- IV
- 147.4%
- B/E move
- 26.6%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.11
- IV
- 147.8%
- B/E move
- 23.7%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.44
- IV
- 148.2%
- B/E move
- 20.9%
35Δ
- Pseudo strike
- 10.48
- IV
- 247.0%
- B/E move
- 52.3%
- Pseudo strike
- 6.77
- IV
- 148.6%
- B/E move
- 18.1%
40Δ
- Pseudo strike
- 9.44
- IV
- 214.9%
- B/E move
- 38.6%
- Pseudo strike
- 7.10
- IV
- 149.0%
- B/E move
- 15.2%
45Δ
- Pseudo strike
- 8.74
- IV
- 191.5%
- B/E move
- 29.9%
- Pseudo strike
- 7.43
- IV
- 149.4%
- B/E move
- 12.4%
50Δ
- Pseudo strike
- 8.05
- IV
- 168.1%
- B/E move
- 21.1%
- Pseudo strike
- 7.86
- IV
- 152.8%
- B/E move
- 10.8%
55Δ
- Pseudo strike
- 7.43
- IV
- 149.7%
- B/E move
- 13.8%
- Pseudo strike
- 8.31
- IV
- 157.1%
- B/E move
- 9.5%
60Δ
- Pseudo strike
- 7.09
- IV
- 150.6%
- B/E move
- 12.1%
- Pseudo strike
- 8.75
- IV
- 161.3%
- B/E move
- 8.2%
65Δ
- Pseudo strike
- 6.75
- IV
- 151.5%
- B/E move
- 10.4%
- Pseudo strike
- 9.20
- IV
- 165.5%
- B/E move
- 6.9%
70Δ
- Pseudo strike
- 6.41
- IV
- 152.4%
- B/E move
- 8.7%
- Pseudo strike
- 9.65
- IV
- 169.7%
- B/E move
- 5.6%
75Δ
- Pseudo strike
- 6.07
- IV
- 153.3%
- B/E move
- 7.1%
- Pseudo strike
- 10.59
- IV
- 188.0%
- B/E move
- 4.6%
80Δ
- Pseudo strike
- 5.73
- IV
- 154.2%
- B/E move
- 5.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 97.59% | |
| 96.46% | |
| 114.91% | |
| 109.61% | |
| 108.38% | |
| 119.80% | |
| 102.62% | |
| 105.73% |
Drug Manufacturers - Specialty & Generic
TLPH
Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs. Its promising pipeline,…
More →TLRY
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
More →TRLV
Trulieve Cannabis Corp. (TRLV) is a prominent player in the US cannabis market, distinguished by its comprehensive vertical integration that encompasses cultivation, production,…
More →TXMD
TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
More →UTHR
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with…
More →VTRS
Description unavailable
More →